Giorgia Antonelli1, Filippo Ceccato2, Carlo Artusi3, Mariela Marinova3, Mario Plebani4. 1. U.O.C. of Laboratory Medicine, Department of Medicine, University of Padova, Padova, Italy. Electronic address: giorgia.antonelli@unipd.it. 2. U.O. of Endocrinology, Department of Medicine, University of Padova, Padova, Italy. 3. Department of Laboratory Medicine, University-Hospital of Padova, Padova, Italy. 4. U.O.C. of Laboratory Medicine, Department of Medicine, University of Padova, Padova, Italy; Department of Laboratory Medicine, University-Hospital of Padova, Padova, Italy.
Abstract
BACKGROUND: The Endocrine Society recommends late-night salivary cortisol (LNS-F) as a first-line screening test for Cushing's syndrome (CS). In the parotid gland, 11β-hydroxysteroid dehydrogenase type 2 inactivates cortisol (F) to cortisone (E), a known source of interference in the more frequently used immunoassays. A highly specific method is mandatory in determining salivary F and E: it is widely accepted that liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the best available technique for this purpose. METHODS: A LC-MS/MS method with SPE of saliva samples was developed and validated. Appropriate awakening and bedtime reference ranges were established. The diagnostic performance for F, E and the ratio at bedtime was evaluated in 25 cases of CS. RESULTS: The method was linear, with up to 55.4 nmol/L and 51.0 nmol/L, LLOQ of 0.51 nmol/L and 0.55 nmol/L, for F and E, respectively. Within-run and between-run imprecisions were <10% for both analytes. No ion suppression was observed. A cut-off of 2.4 nmol/L for LNS-F yielded a sensitivity of 100% and a specificity of 98% in the diagnosis of CS. CONCLUSIONS: The analytical performance of this method justifies its introduction into clinical practice, thus allowing clinicians the opportunity to further investigate CS and other endocrine diseases.
BACKGROUND: The Endocrine Society recommends late-night salivary cortisol (LNS-F) as a first-line screening test for Cushing's syndrome (CS). In the parotid gland, 11β-hydroxysteroid dehydrogenase type 2 inactivates cortisol (F) to cortisone (E), a known source of interference in the more frequently used immunoassays. A highly specific method is mandatory in determining salivary F and E: it is widely accepted that liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the best available technique for this purpose. METHODS: A LC-MS/MS method with SPE of saliva samples was developed and validated. Appropriate awakening and bedtime reference ranges were established. The diagnostic performance for F, E and the ratio at bedtime was evaluated in 25 cases of CS. RESULTS: The method was linear, with up to 55.4 nmol/L and 51.0 nmol/L, LLOQ of 0.51 nmol/L and 0.55 nmol/L, for F and E, respectively. Within-run and between-run imprecisions were <10% for both analytes. No ion suppression was observed. A cut-off of 2.4 nmol/L for LNS-F yielded a sensitivity of 100% and a specificity of 98% in the diagnosis of CS. CONCLUSIONS: The analytical performance of this method justifies its introduction into clinical practice, thus allowing clinicians the opportunity to further investigate CS and other endocrine diseases.
Authors: K Mészáros; G Karvaly; Z Márta; B Magda; J Tőke; N Szücs; M Tóth; K Rácz; A Patócs Journal: J Endocrinol Invest Date: 2017-08-16 Impact factor: 4.256
Authors: F Ceccato; G Marcelli; M Martino; C Concettoni; M Brugia; L Trementino; G Michetti; G Arnaldi Journal: J Endocrinol Invest Date: 2018-07-09 Impact factor: 4.256
Authors: Karolina Elżbieta Kaczor-Urbanowicz; Carmen Martin Carreras-Presas; Katri Aro; Michael Tu; Franklin Garcia-Godoy; David Tw Wong Journal: Exp Biol Med (Maywood) Date: 2016-12-08
Authors: Graeme Eisenhofer; Mirko Peitzsch; Denise Kaden; Katharina Langton; Christina Pamporaki; Jimmy Masjkur; George Tsatsaronis; Anastasios Mangelis; Tracy A Williams; Martin Reincke; Jacques W M Lenders; Stefan R Bornstein Journal: Clin Chim Acta Date: 2017-05-04 Impact factor: 3.786
Authors: Marloes L P Langelaan; Jérôme M H Kisters; Mirjam M Oosterwerff; Arjen-Kars Boer Journal: Endocr Connect Date: 2018-03-12 Impact factor: 3.335
Authors: Joshua Kannankeril; Ty Carroll; James W Findling; Bradley Javorsky; Ian L Gunsolus; Jonathan Phillips; Hershel Raff Journal: J Endocr Soc Date: 2020-07-24